Partner With DrugPatentWatch
Listen to this article Copyright © DrugPatentWatch. Originally published at Partner With DrugPatentWatch Partner With DrugPatentWatch Become a Data Integration Partner DrugPatentWatch’s Data Integration Program is for companies that want…
Read more
Try our one-month starter plans
Listen to this article Copyright © DrugPatentWatch. Originally published at Try our one-month starter plans Do you want an easier way to access DrugPatentWatch without a long-term commitment? We have monthly…
Read more
Gain Intelligence on Royalties, Settlements, and More with Drug Patent Litigation Information
Listen to this article Copyright © DrugPatentWatch. Originally published at Gain Intelligence on Royalties, Settlements, and More with Drug Patent Litigation Information Disclosure: the majority of the companies mentioned below…
Read more
How to Use Tentative Drug Approvals to Anticipate Generic Entry
Listen to this article Copyright © DrugPatentWatch. Originally published at How to Use Tentative Drug Approvals to Anticipate Generic Entry Which Company Will be the First to Launch a Generic…
Read more
Generic Drug Launch Dates – A 1-step Solution to Navigate the Web of Drug Patents and Regulatory Protections
Listen to this article Copyright © DrugPatentWatch. Originally published at Generic Drug Launch Dates – A 1-step Solution to Navigate the Web of Drug Patents and Regulatory Protections Drugs can…
Read more

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare
and is included in one NDA. There are two patents protecting this compound.

This ingredient has seventy-one patent family members in thirty-seven countries.

Three suppliers are listed for this compound. There is one tentative approval for this compound.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Published in Tentative Approval

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Share this:

Related